findmyKOL
Clinical trialNCT01802281CompletedInterventional

Study of Uterine Prolapse Procedures - Randomized Trial

SponsorNICHD Pelvic Floor Disorders NetworkEnrollment183Uterovaginal Prolapse
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Anthony G Visco, MD

    Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery

    Principal Investigator
  • Charles R Rardin, MD

    Brown/ Women and Infants Hospital of Rhode Island, Center for Women's Pelvic Medicine and Reconstructive Surgery

    Principal Investigator
  • Charles W Nager, MD

    University of California at San Diego, UCSD Women's Pelvic Medicine Center

    Principal Investigator
  • Halina M Zyczynski, MD

    Magee-Women's Hospital, Department of Obstetrics and Gynecology

    Principal Investigator
  • Heidi Harvie, MD

    University of Pennsylvania

    Principal Investigator
  • Holly E Richter, PhD, MD

    University of Alabama at Birmingham, Department of Obstetrics and Gynecology

    Principal Investigator
  • Kate Meriwether, MD

    University of New Mexico Health Sciences Center, Department of Obstetrics and Gynecology

    Principal Investigator
  • Marie Paraiso, MD

    Cleveland Clinic, Department OB/GYN

    Principal Investigator
  • Sonia Thomas, DrPH

    RTI International

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham, Department of Obstetrics and Gynecology

    Birmingham, Alabama, United States

  • University of California at San Diego, Ucsd Women'S Pelvic Medicine Center

    La Jolla, California, United States

  • University of New Mexico Health Sciences Center, Department of Obstetrics and Gynecology

    Albuquerque, New Mexico, United States

  • Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery

    Durham, North Carolina, United States

  • Cleveland Clinic, Department Ob/gyn

    Cleveland, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Magee-Women'S Hospital, Department of Obstetrics and Gynecology

    Pittsburgh, Pennsylvania, United States

  • Brown/ Women and Infants Hospital of Rhode Island, Center for Women'S Pelvic Medicine and Reconstructive Surgery

    Providence, Rhode Island, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2013
Primary completion
31 Jul 2023
Completion
7 Mar 2025
Last update posted
26 Aug 2025
Registered enrollment
183
Registry id
NCT01802281

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.